BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17200366)

  • 1. The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells.
    Sakimura R; Tanaka K; Yamamoto S; Matsunobu T; Li X; Hanada M; Okada T; Nakamura T; Li Y; Iwamoto Y
    Clin Cancer Res; 2007 Jan; 13(1):275-82. PubMed ID: 17200366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
    Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
    Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228).
    Sutheesophon K; Nishimura N; Kobayashi Y; Furukawa Y; Kawano M; Itoh K; Kano Y; Ishii H; Furukawa Y
    J Cell Physiol; 2005 May; 203(2):387-97. PubMed ID: 15515013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
    Lai JP; Yu C; Moser CD; Aderca I; Han T; Garvey TD; Murphy LM; Garrity-Park MM; Shridhar V; Adjei AA; Roberts LR
    Gastroenterology; 2006 Jun; 130(7):2130-44. PubMed ID: 16762634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
    Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T
    Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.
    Hoshino I; Matsubara H; Hanari N; Mori M; Nishimori T; Yoneyama Y; Akutsu Y; Sakata H; Matsushita K; Seki N; Ochiai T
    Clin Cancer Res; 2005 Nov; 11(21):7945-52. PubMed ID: 16278420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines.
    Hartlapp I; Pallasch C; Weibert G; Kemkers A; Hummel M; Re D
    Leuk Res; 2009 Jul; 33(7):929-36. PubMed ID: 19233470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines.
    Yamamoto S; Tanaka K; Sakimura R; Okada T; Nakamura T; Li Y; Takasaki M; Nakabeppu Y; Iwamoto Y
    Anticancer Res; 2008; 28(3A):1585-91. PubMed ID: 18630516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY; Jung JH; Na YJ; Kim HS
    Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.
    Vinodhkumar R; Song YS; Devaki T
    Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.
    Tabe Y; Jin L; Contractor R; Gold D; Ruvolo P; Radke S; Xu Y; Tsutusmi-Ishii Y; Miyake K; Miyake N; Kondo S; Ohsaka A; Nagaoka I; Andreeff M; Konopleva M
    Cell Death Differ; 2007 Aug; 14(8):1443-56. PubMed ID: 17464329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation.
    Savickiene J; Treigyte G; Borutinskaite V; Navakauskiene R; Magnusson KE
    Ann N Y Acad Sci; 2006 Dec; 1091():368-84. PubMed ID: 17341629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
    Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities.
    Konstantinopoulos PA; Vandoros GP; Papavassiliou AG
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):711-5. PubMed ID: 16435156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
    Kanao K; Mikami S; Mizuno R; Shinojima T; Murai M; Oya M
    J Urol; 2008 Sep; 180(3):1131-6. PubMed ID: 18639283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins.
    Bordin M; D'Atri F; Guillemot L; Citi S
    Mol Cancer Res; 2004 Dec; 2(12):692-701. PubMed ID: 15634758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis.
    Yamamura K; Ohishi K; Katayama N; Yu Z; Kato K; Masuya M; Fujieda A; Sugimoto Y; Miyata E; Shibasaki T; Heike Y; Takaue Y; Shiku H
    Br J Haematol; 2006 Oct; 135(2):242-53. PubMed ID: 16939493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM; Liu JC
    J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblast growth factor inhibits p38-mediated cell differentiation and growth inhibition by activin A but not by histone deacetylase inhibitors in CML cells.
    Chen CH; Lin JY; Liu FH; Chang JL; Huang HM
    Ann Hematol; 2008 Mar; 87(3):175-82. PubMed ID: 17929017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.